Proteomics International Laboratories (ASX:PIQ) Ending Cash Position : A$4.97 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Proteomics International Laboratories Ending Cash Position?

Proteomics International Laboratories's Ending Cash Position for the quarter that ended in Dec. 2023 was A$4.97 Mil.

Proteomics International Laboratories's quarterly Ending Cash Position declined from Dec. 2022 (A$6.82 Mil) to Jun. 2023 (A$6.03 Mil) and declined from Jun. 2023 (A$6.03 Mil) to Dec. 2023 (A$4.97 Mil).

Proteomics International Laboratories's annual Ending Cash Position declined from Jun. 2021 (A$5.61 Mil) to Jun. 2022 (A$2.11 Mil) but then increased from Jun. 2022 (A$2.11 Mil) to Jun. 2023 (A$6.03 Mil).

Proteomics International Laboratories Ending Cash Position Historical Data

The historical data trend for Proteomics International Laboratories's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Proteomics International Laboratories Ending Cash Position Chart

Proteomics International Laboratories Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Ending Cash Position

Get a 7-Day Free Trial

1.51

2.37

5.61

2.11

6.03

Proteomics International Laboratories Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Ending Cash Position	Get a 7-Day Free Trial													4.55	2.11	6.82	6.03	4.97

Proteomics International Laboratories Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Proteomics International Laboratories's Ending Cash Position for the fiscal year that ended in Jun. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	2.111	+	3.916
	=	6.03

Proteomics International Laboratories's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	6.028	+	-1.058
	=	4.97

Proteomics International Laboratories Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Proteomics International Laboratories's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Proteomics International Laboratories (ASX:PIQ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Proteomics International Laboratories Ltd (ASX:PIQ) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

6 Verdun Street, QEII Medical Centre, QQ Block, Nedlands, Perth, WA, AUS, 6009

Website

https://www.proteomics.com.au

Proteomics International Laboratories Ltd is a biological research and drug discovery company. The company specializes in the area of proteomics which is the industrial-scale study of the structure and function of proteins. Its operations are divided into PromarkerD which targets the diabetes epidemic and is a predictive diagnostic test for diabetic kidney disease, a progressive disorder found in one in three adults with diabetes; its proprietary biomarker discovery platform called Promarker, which searches for protein fingerprints in a sample; and Analytical Services that are specialist contract research focusing on biosimilars quality control and pharmacokinetic testing for clinical trials.

Proteomics International Laboratories (ASX:PIQ) Headlines

No Headlines